Japanese Regulators Enforce Label Change For Flu Drugs Due To Abnormal Behavior
This article was originally published in PharmAsia News
Executive Summary
Drugs containing zanamivir hydrate or amantadine hydrochloride, ingredients commonly used in anti-influenza treatments, will have to change their labels immediately, Japan's Ministry of Health, Labour and Welfare (MHLW) announced Dec. 26